Cargando…

Possible role of nanocarriers in drug delivery against cervical cancer

Introduction: Cervical cancer is the second most common cancer and the largest cancer killer among women in most developing countries including India. Although, various drugs have been developed for cervical cancer, treatment with these drugs often results in a number of undesirable side effects, to...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Swati, Gupta, Manish K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167030/
https://www.ncbi.nlm.nih.gov/pubmed/30410707
http://dx.doi.org/10.1080/20022727.2017.1335567
_version_ 1783360131020357632
author Gupta, Swati
Gupta, Manish K.
author_facet Gupta, Swati
Gupta, Manish K.
author_sort Gupta, Swati
collection PubMed
description Introduction: Cervical cancer is the second most common cancer and the largest cancer killer among women in most developing countries including India. Although, various drugs have been developed for cervical cancer, treatment with these drugs often results in a number of undesirable side effects, toxicity and multidrug resistance (MDR). Also, the outcomes for cervical cancer patients remain poor after surgery and chemo radiation. Methods: A literature search (for drugs and delivery systems against cervical cancer) was performed on PubMed and through Google. The present review discuss about various methods including its current conventional treatment with special reference to recent advances in delivery systems encapsulating various anticancer drugs and natural plant products for targeting towards cervical cancer. The role of photothermal therapy, gene therapy and radiation therapy against cervical cancer is also discussed. Results: Systemic/targeted drug delivery systems including liposomes, nanoparticles, hydrogels, dendrimers etc. and localized drug delivery systems like cervical patches, films, rings etc. are safer than the conventional chemotherapy which has further been proved by the several drug delivery systems undergoing clinical trials. Conclusion: Novel approaches for the aggressive treatment of cervical cancer will optimistically result in decreased side effects as well as toxicity, frequency of administration of existing drugs, to overcome MDR and to increase the survival rates.
format Online
Article
Text
id pubmed-6167030
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-61670302018-10-02 Possible role of nanocarriers in drug delivery against cervical cancer Gupta, Swati Gupta, Manish K. Nano Rev Exp Review Article Introduction: Cervical cancer is the second most common cancer and the largest cancer killer among women in most developing countries including India. Although, various drugs have been developed for cervical cancer, treatment with these drugs often results in a number of undesirable side effects, toxicity and multidrug resistance (MDR). Also, the outcomes for cervical cancer patients remain poor after surgery and chemo radiation. Methods: A literature search (for drugs and delivery systems against cervical cancer) was performed on PubMed and through Google. The present review discuss about various methods including its current conventional treatment with special reference to recent advances in delivery systems encapsulating various anticancer drugs and natural plant products for targeting towards cervical cancer. The role of photothermal therapy, gene therapy and radiation therapy against cervical cancer is also discussed. Results: Systemic/targeted drug delivery systems including liposomes, nanoparticles, hydrogels, dendrimers etc. and localized drug delivery systems like cervical patches, films, rings etc. are safer than the conventional chemotherapy which has further been proved by the several drug delivery systems undergoing clinical trials. Conclusion: Novel approaches for the aggressive treatment of cervical cancer will optimistically result in decreased side effects as well as toxicity, frequency of administration of existing drugs, to overcome MDR and to increase the survival rates. Taylor & Francis 2017-07-07 /pmc/articles/PMC6167030/ /pubmed/30410707 http://dx.doi.org/10.1080/20022727.2017.1335567 Text en © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Gupta, Swati
Gupta, Manish K.
Possible role of nanocarriers in drug delivery against cervical cancer
title Possible role of nanocarriers in drug delivery against cervical cancer
title_full Possible role of nanocarriers in drug delivery against cervical cancer
title_fullStr Possible role of nanocarriers in drug delivery against cervical cancer
title_full_unstemmed Possible role of nanocarriers in drug delivery against cervical cancer
title_short Possible role of nanocarriers in drug delivery against cervical cancer
title_sort possible role of nanocarriers in drug delivery against cervical cancer
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167030/
https://www.ncbi.nlm.nih.gov/pubmed/30410707
http://dx.doi.org/10.1080/20022727.2017.1335567
work_keys_str_mv AT guptaswati possibleroleofnanocarriersindrugdeliveryagainstcervicalcancer
AT guptamanishk possibleroleofnanocarriersindrugdeliveryagainstcervicalcancer